Jubilant Pharmova Closes Trading Window for Q2 FY27 Results

Jubilant Pharmova Limited has announced the closure of its trading window for dealing in the company's securities. This closure is effective from October 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company has informed all Designated Persons and their Immediate Relatives about this restriction, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The exact date of the board meeting to approve these financial results will be communicated separately. The information will also be available on the company's website.